Companies: 10,795·Total market cap: $144.5T
Ascentage Pharma Group International

Ascentage Pharma Group International

ASPHFOTCHealthcare● Active
$4.53
$-0.17(-3.51%)
Market Cap$1.7B
P/E Ratio—
52W High$10.65
52W Low$4.53
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Ascentage Pharma Group International（ASPHF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ASPHF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-4.85asphf eps ttm · asphf earnings per shareEarnings history
PE Ratio (TTM)—asphf pe ratio ttm · asphf price to earningsPE Ratio deep dive
Revenue (TTM)$1.3Basphf revenue ttm · asphf annual revenueFull revenue history
Dividend Yield不分红does asphf pay dividends · asphf dividend yieldDividend history
Shares Outstanding356.1Masphf shares outstanding · asphf floatShares outstanding history
Next EarningsAug 26, 2026Est.asphf earnings date · asphf next earningsEarnings history

探索 Ascentage Pharma Group International 数据

asphf stock data · financials
市值$1.7Basphf market cap · asphf valuation
分析师预测—
股息不分红does ascentage pharma group international pay dividends · asphf dividend yield
营收$559.3M-42.97%ascentage pharma group international annual revenue · asphf revenue
盈利EPS $-3.43-150.36%asphf earnings · asphf eps
市盈率—asphf pe ratio · asphf price to earnings

财务快照

完整财报
FY 2025Revenue$559.3M▼ 42.97% YoY
202320242025
ascentage pharma group international revenue · asphf revenue 2025
FY 2025Net Income-$1.21B▼ 198.62% YoY
202320242025
ascentage pharma group international net income · asphf profit 2025
FY 2025EPS$-3.43▼ 150.36% YoY
202320242025
asphf eps · ascentage pharma group international earnings per share 2025
TTM:Revenue: $1.35BNet Income: -$1.13BEPS: $-4.85View income statement →

股票表现

完整历史
1D-3.51%
1W-3.62%
1M-46.58%
3M-46.58%
YTD-46.58%
1Y-22.16%
5Y-25.74%

关于 Ascentage Pharma Group International

CEODajun Yang
IPO DateMay 21, 2021
Employees567
CountryCN
Websiteascentagepharma.com

Ascentage Pharma Group International a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United State…

BiotechnologyHealthcareOTCCN

what is ascentage pharma group international · asphf stock overview · ascentage pharma group international company profile · who is ascentage pharma group international ceo · asphf OTC · ascentage pharma group international headquarters · ascentage pharma group international business segments

关于股票概览与关键数据

Ascentage Pharma Group International（ASPHF）是 Biotechnology 行业的 Healthcare 类公司，于 May 21, 2021 在 OTC 上市。截至最近交易日，ASPHF 股价为 $4.53，市值约为 $1.7B。过去12个月累计回报 -22.16%，年初至今回报 -46.58%。

2025 财年 Ascentage Pharma Group International 营收 $559.3M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Ascentage Pharma Group International（ASPHF）股价为 $4.53，在 OTC 上市，52周区间为 $4.53 – $10.65。

ASPHF 最新股价ASPHF quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议